Gufic Biosciences Ltd.
Snapshot View

215.30 +3.90 ▲1.8%

05 December 2022, 04:10:28 PM
Volume: 56,952

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gufic.com
Market Cap 2,086.73 Cr.
Enterprise Value(EV) 2,218.49 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.52 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 25.27 Trailing Twelve Months Ending 2022-09
Industry PE 35.38 Trailing Twelve Months Ending 2022-09
Book Value / Share 31.91 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.75 Calculated using Price: 215.25
Dividend Yield 0.05 Period Ending 2022-03
No. of Shares Subscribed 9.69 Cr. 96,944,506 Shares
FaceValue 1
Company Profile
Gufic Biosciences Ltd. is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.Gufic has entered into hybrid vegetable seeds. Gufic seeds deals in all major vegetable seeds namely, tomato, chilli, cabbage, cauliflower, capsicum, coriander, bhendi, bottle gourd, bitter gourd, ridge gourd, brinjal, cucumber and watermelon.The company has developed in-house, on line real time computer software for forward planning of production schedule to meet market demands as well as monitoring daily production schedule and generating mis reports.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.84%
1 Week
+0.80%
1 Month
-4.90%
3 Month
-7.38%
6 Month
-3.47%
1 Year
+13.98%
2 Year
+81.92%
5 Year
+123.80%
10 Year
+3137.59%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.55 15.60 23.99 25.31 36.03 33.89 22.17 29.22 43.31
Return on Capital Employed (%) 17.45 18.38 24.24 24.26 34.10 29.65 21.01 30.05 47.10
Return on Assets (%) 4.25 3.49 5.24 5.52 8.04 8.04 5.65 10.00 20.98

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 26 27 34 37 54 75 129 173 269 309
Non Curr. Liab. 25 17 15 9 13 17 38 55 65 130
Curr. Liab. 60 84 104 128 169 218 326 164 187 255
Minority Int.
Equity & Liab. 111 127 152 175 235 310 493 392 521 694
Non Curr. Assets 42 36 33 31 37 46 134 131 201 260
Curr. Assets 69 91 120 143 198 264 359 261 321 435
Misc. Exp. not W/O
Total Assets 111 127 152 175 235 310 493 392 521 694

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 123 152 202 246 306 351 379 488 779 674
Other Income 1 1 1 1 3 4 6 4 3 3
Total Income 124 152 203 247 308 355 385 491 782 677
Total Expenditure -111 -137 -183 -223 -267 -305 -327 -404 -633 -544
PBIDT 13 15 20 24 42 50 58 88 149 133
Interest -4 -4 -6 -6 -9 -10 -14 -14 -5 -5
Depreciation -2 -4 -4 -4 -4 -5 -14 -16 -17 -18
Taxation -2 -2 -3 -5 -13 -13 -7 -13 -31 -28
Exceptional Items 2
PAT 4 4 7 9 16 22 23 44 96 83
Adjusted EPS 1 1 1 1 2 3 2 5 10 9

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 11 11 -4 -4 -5 5 47 87 104
Cash Fr. Inv. -13 -3 -2 -1 -5 -9 -13 -43 -7 -96
Cash Fr. Finan. 8 -7 -5 5 7 14 8 -4 -79 -3
Net Change 0 1 4 0 -1 1 0 0 2 5
Cash & Cash Eqvt 1 3 6 6 3 4 4 4 6 12

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 65.75 65.75 65.75 65.13 75.48 75.48 75.48 75.00 75.00
Public 34.25 34.25 34.25 34.87 24.52 24.52 24.52 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 18 Nov 2022
Transcript of Analysts/Institutional Investor Meet/Con. Call
Gufic Biosciences Limited has informed the Exchange about Written Transcript of Analysts/Institutional Investor Meet/Con. Call
Tue, 15 Nov 2022
Recording of Analysts/Institutional Investor Meet/Con. Call
Gufic Biosciences Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call
Mon, 07 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Gufic Biosciences Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Mon, 05 Dec 2022
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,386.88 1,039.40 -0.1%
Cipla Ltd. 90,016.94 1,115.35 +0.1%
Divi's Laboratories Ltd. 89,432.38 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. 74,582.06 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. 68,701.75 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. 54,598.02 1,613.20 -0.4%
Abbott India Ltd. 42,923.27 20,059.40 -0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.65 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-09 35.09 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.88 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.99 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 81.83 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.50 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-09 48.68 20,059.40 -0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.69 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-09 4.11 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.59 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.48 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.96 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-09 15.81 20,059.40 -0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,059.40 -0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,059.40 -0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,059.40 -0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,059.40 -0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,039.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,368.85 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,479.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,778.10 -1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,613.20 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,059.40 -0.6%

FAQ's On Gufic Biosciences Ltd.

What is Gufic Biosciences share price?

Can I buy Gufic Biosciences shares now?

What is the Dividend Yield of Gufic Biosciences?

What is the Market Cap of Gufic Biosciences?

What are the key metrics to analyse Gufic Biosciences?

What is the 52 Week High and Low of Gufic Biosciences?

What is the trend of Gufic Biosciences share price?